West Pharmaceutical Services Inc (WST)
320.88
+9.22
(+2.96%)
USD |
NYSE |
Nov 21, 16:00
325.19
+4.31
(+1.34%)
Pre-Market: 09:03
West Pharmaceutical Services Debt to Equity Ratio: 0.0736 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
September 30, 2024 | 0.0736 |
June 30, 2024 | 0.0799 |
March 31, 2024 | 0.0769 |
December 31, 2023 | 0.0718 |
September 30, 2023 | 0.0723 |
June 30, 2023 | 0.0757 |
March 31, 2023 | 0.075 |
December 31, 2022 | 0.0778 |
September 30, 2022 | 0.0847 |
June 30, 2022 | 0.1039 |
March 31, 2022 | 0.1085 |
December 31, 2021 | 0.1083 |
September 30, 2021 | 0.1154 |
June 30, 2021 | 0.125 |
March 31, 2021 | 0.1392 |
December 31, 2020 | 0.1376 |
September 30, 2020 | 0.1488 |
June 30, 2020 | 0.1595 |
March 31, 2020 | 0.1723 |
December 31, 2019 | 0.1636 |
September 30, 2019 | 0.1312 |
June 30, 2019 | 0.1356 |
March 31, 2019 | 0.1428 |
December 31, 2018 | 0.1404 |
September 30, 2018 | 0.1451 |
Date | Value |
---|---|
June 30, 2018 | 0.1532 |
March 31, 2018 | 0.1517 |
December 31, 2017 | 0.1539 |
September 30, 2017 | 0.1745 |
June 30, 2017 | 0.1847 |
March 31, 2017 | 0.1956 |
December 31, 2016 | 0.2046 |
September 30, 2016 | 0.2024 |
June 30, 2016 | 0.2086 |
March 31, 2016 | 0.216 |
December 31, 2015 | 0.2912 |
September 30, 2015 | 0.3039 |
June 30, 2015 | 0.3302 |
March 31, 2015 | 0.3514 |
December 31, 2014 | 0.3506 |
September 30, 2014 | 0.3533 |
June 30, 2014 | 0.3717 |
March 31, 2014 | 0.4332 |
December 31, 2013 | 0.4121 |
September 30, 2013 | 0.4781 |
June 30, 2013 | 0.5034 |
March 31, 2013 | 0.5766 |
December 31, 2012 | 0.5645 |
September 30, 2012 | 0.5598 |
June 30, 2012 | 0.5673 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0718
Minimum
Dec 2023
0.1723
Maximum
Mar 2020
0.1085
Average
0.1061
Median
Debt to Equity Ratio Benchmarks
Repligen Corp | 0.2586 |
Perspective Therapeutics Inc | -- |
Retractable Technologies Inc | 0.0157 |
Xtant Medical Holdings Inc | 0.7605 |
Catheter Precision Inc | 0.1364 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 3.675B |
Total Liabilities (Quarterly) | 923.00M |
Shareholders Equity (Quarterly) | 2.752B |
Current Ratio | 3.002 |
Net Debt Paydown Yield | 0.00% |